A phase II clinical trial of palonosetron for the management of delayed vomiting in gynecological cancer patients receiving paclitaxel/carboplatin therapy

There are currently no studies demonstrating the effects of palonosetron on delayed chemotherapy-induced nausea and vomiting (CINV) in gynecological cancer patients receiving chemotherapy with moderately emetogenic chemotherapeutic agents. We conducted a phase II clinical trial to assess the efficac...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Mol Clin Oncol
Auteurs principaux: TAKATORI, ERIKO, SHOJI, TADAHIRO, MIURA, YUKI, NAGAO, MIYUKI, TAKADA, ANNA, NAGASAWA, TAKAYUKI, OMI, HIDEO, KAGABU, MASAHIRO, HONDA, TATSUYA, SUGIYAMA, TORU
Format: Artigo
Langue:Inglês
Publié: D.A. Spandidos 2015
Sujets:
Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4360756/
https://ncbi.nlm.nih.gov/pubmed/25798254
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2015.484
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires